The risk of mental health challenges such as psychosis or suicidality in supervised clinical configurations amongst those who get involved in research on psilocybin is low. On top of that, research trials have not bundled people who have schizophrenia or psychosis, as There may be reasonable issue that psilocybin (or other psychedelics) Within t